Archive for September, 2019

  • Poster ESMO 2019

    Isofol Announces Presentation on the Global Phase 3 Study of arfolitixorin in Metastatic Colorectal Cancer at 2019 ESMO Congress GOTHENBURG,…

    by
  • Isofol Announces Presentation on the Global Phase 3 Study of arfolitixorin in Metastatic Colorectal Cancer at 2019 ESMO Congress

    GOTHENBURG, Sweden, September 29, 2019 - Isofol Medical AB (publ), (Nasdaq First North Premier: ISOFOL), today announced a poster presentation…

    by
  • Published abstract at ESMO

    Published abstract at ESMO “Open label phase III study of arfolitixorin vs leucovorin in mFOLFOX-6 for first-line treatment of metastatic…

    by
  • Isofol Announces that an Abstract has been Accepted for Presentation at the 2019 ESMO Congress

    Isofol Announces that an Abstract has been Accepted for Presentation at the 2019 ESMO Congress GOTHENBURG, Sweden, September 12, 2019…

    by
  • Isofol Announces that an Abstract has been Accepted for Presentation at the 2019 ESMO Congress

    GOTHENBURG, Sweden, September 12, 2019 - Isofol Medical AB (publ), (Nasdaq First North Premier: ISOFOL), today announced that an abstract…

    by